Pyrazinamide resistance among multidrug-resistant tuberculosis clinical isolates in a national referral center of China and its correlations with pncA, rpsA, and panD gene mutations

Diagnostic Microbiology and Infectious Disease

Volumn 84, Issue 3, 2016, Pages 207-211

  Gu, Yunting ^a   Yu, Xia ^a   Jiang, Guanglu ^a   Wang, Xiaobo ^a   Ma, Yifeng ^a   Li, Yunxu ^a   Huang, Hairong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

PncA; Pyrazinamide; Resistance; RpsA; Tuberculosis

Indexed keywords

AMINOGLYCOSIDE; CAPREOMYCIN; ETHAMBUTOL; ISONIAZID; LEVOFLOXACIN; OFLOXACIN; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; CHINA; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; FEMALE; GENE SEQUENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR DYNAMICS; MULTIDRUG RESISTANT TUBERCULOSIS; NONHUMAN; OPEN READING FRAME; PAND GENE; PNCA GENE; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; RPSA GENE; SENSITIVITY AND SPECIFICITY; AMINO ACID SUBSTITUTION; CODON; DNA SEQUENCE; DRUG EFFECT; GENETICS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MUTATION; MYCOBACTERIUM TUBERCULOSIS; YOUNG ADULT;

ADULT; AGED; AMINO ACID SUBSTITUTION; ANTITUBERCULAR AGENTS; CHINA; CODON; DRUG RESISTANCE, BACTERIAL; FEMALE; GENES, BACTERIAL; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MUTATION; MYCOBACTERIUM TUBERCULOSIS; OPEN READING FRAMES; PROMOTER REGIONS, GENETIC; PYRAZINAMIDE; SEQUENCE ANALYSIS, DNA; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

EID: 84958659321     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2015.10.017     Document Type: Article

References (21)

1. Alexander D.C., Ma J.H., Guthrie J.L., Blair J., Chedore P., Jamieson F.B. Gene sequencing for routine verification of pyrazinamide resistance in Mycobacterium tuberculosis: a role for pncA but not rpsA. J Clin Microbiol 2012, 50:3726-3728.
2. Ando H., Mitarai S., Kondo Y., Suetake T., Sekiguchi J.I., Kato S., et al. Pyrazinamide resistance in multidrug-resistant Mycobacterium tuberculosis isolates in Japan. Clin Microbiol Infect 2010, 16:1164-1168.
3. Barco P., Cardoso R.F., Hirata R.D., Leite C.Q., Pandolfi J.R., Sato D.N., et al. pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis clinical isolates from the southeast region of Brazil. J Antimicrob Chemother 2006, 58:930-935.
4. Bhuju S., Fonseca Lde S., Marsico A.G., de Oliveira Vieira G.B., Sobral L.F., Stehr M., et al. Mycobacterium tuberculosis isolates from Rio de Janeiro reveal unusually low correlation between pyrazinamide resistance and mutations in the pncA gene. Infect Genet Evol 2013, 19:1-6.
5. Doustdar F., Khosravi A.D., Farnia P. Mycobacterium tuberculosis genotypic diversity in pyrazinamide-resistant isolates of Iran. Microb Drug Resist 2009, 15:251-256.
6. Hou L., Osei-Hyiaman D., Zhang Z., Wang B., Yang A., Kano K. Molecular characterization of pncA gene mutations in Mycobacterium tuberculosis clinical isolates from China. Epidemiol Infect 2000, 124:227-232.
7. Jonmalung J., Prammananan T., Leechawengwongs M., Chaiprasert A. Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand. BMC Microbiol 2010, 10:223.
8. Mitchison D.A. The action of antituberculosis drugs in short-course chemotherapy. Tubercle 1985, 66:219-225.
9. Morlock G.P., Crawford J.T., Butler W.R., Brim S.E., Sikes D., Mazurek G.H., et al. Phenotypic characterization of pncA mutants of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2000, 44:2291-2295.
10. Mphahlele M., Syre H., Valvatne H., Stavrum R., Mannsaker T., Muthivhi T., et al. Pyrazinamide resistance among South African multidrug-resistant Mycobacterium tuberculosis isolates. J Clin Microbiol 2008, 46:3459-3464.
11. Scarparo C., Ricordi P., Ruggiero G., Piccoli P. Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide, streptomycin, isoniazid, rifampin, and ethambutol and comparison with the radiometric BACTEC 460 TB method. J Clin Microbiol 2004, 42:1109-1114.
12. Scorpio A., Zhang Y. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nat Med 1996, 2:662-667.
13. Sharma B., Pal N., Malhotra B., Vyas L., Rishi S. Comparison of MGIT 960 & pyrazinamidase activity assay for pyrazinamide susceptibility testing of Mycobacterium tuberculosis. Indian J Med Res 2010, 132:72-76.
14. Shi W., Zhang X., Jiang X., Yuan H., Lee J.S., Barry C.E., et al. Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis. Science 2011, 333:1630-1632.
15. Shi Wl, Chen Jz, Feng J., Cui P., Zhang Shuo, Weng Xinhua, et al. Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis. Emerg Microbes Infect 2014, 3:e58.
16. Tan Y., Hu Z., Zhang T., Cai X., Kuang H., Liu Y., et al. Role of pncA and rpsA gene sequencing in detection of pyrazinamide resistance in Mycobacterium tuberculosis isolates from southern China. J Clin Microbiol 2014, 52:291-297.
17. World Health Organization (WHO) Anti-tuberculosis drug resistance in the world. Report no. 4 2008.
18. World Health Organization (WHO) Guidelines for surveillance of drug resistance in tuberculosis 2009, WHO, Geneva. 4th ed.
19. Xia Q., Zhao L.L., Li F., Fan Y.M., Chen Y.Y., Wu B.B., et al. Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Zhejiang, China. Antimicrob Agents Chemother 2015, 59:1690-1695.
20. Zhang S., Chen Jz, Shi Wl, Liu W., Zhang Wh., Zhang Y. Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis. Emerg Microbes Infect 2013, 2:e34.
21. Zhao Y., Xu S., Wang L., Chin D.P., Wang S., Jiang G., et al. National survey of drug-resistant tuberculosis in China. N Engl J Med 2012, 366:2161-2170.